Literature DB >> 3720025

Studies of the effect of mitoxantrone on adjuvant induced arthritis in rats.

A E Sloboda, A L Oronsky, S S Kerwar.   

Abstract

When rats with developing or established adjuvant arthritis are treated with mitoxantrone, the hind paw inflammation associated with the disease is inhibited. Radiographic analysis of the hind paws indicates that the agent suppresses joint destruction associated with the lesion. Comparative studies with cyclophosphamide indicate that mitoxantrone is more efficacious and at least 20 times more potent than cyclophosphamide. Mitoxantrone also appeared more effective when given by the subcutaneous route than the peritoneal route of administration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720025     DOI: 10.1016/0090-1229(86)90026-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

Review 1.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 2.  Mitoxantrone: a review of its use in multiple sclerosis.

Authors:  Lesley J Scott; David P Figgitt
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Effect of Tripterygium Wilfordii on adrenal cortex in rat with adjuvant arthritis.

Authors:  M M Zhang; P L Liu; W Y Ye
Journal:  J Tongji Med Univ       Date:  1994

4.  Treatment of multiple sclerosis with mitoxantrone.

Authors:  E Mauch; H H Kornhuber; H Krapf; U Fetzer; H Laufen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

5.  Streptococcal cell wall arthritis. Passive transfer of disease with a T cell line and crossreactivity of streptococcal cell wall antigens with Mycobacterium tuberculosis.

Authors:  S Q DeJoy; K M Ferguson; T M Sapp; J B Zabriskie; A L Oronsky; S S Kerwar
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

6.  Does physical exercise improve or deteriorate treatment of multiple sclerosis with mitoxantrone? Experimental autoimmune encephalomyelitis study in rats.

Authors:  Mohamed A El-Emam; Samar El Achy; Dalaal M Abdallah; Hanan S El-Abhar; Mennatallah A Gowayed
Journal:  BMC Neurosci       Date:  2022-03-05       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.